ADAPTIMMUNE Trademark

Trademark Overview


On Monday, June 29, 2015, a trademark application was filed for ADAPTIMMUNE with the United States Patent and Trademark Office. The USPTO has given the ADAPTIMMUNE trademark a serial number of 79171893. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Thursday, June 9, 2022. This trademark is owned by Adaptimmune Limited. The ADAPTIMMUNE trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of cancer and autoimmune diseases

Medical treatment services, namely, administration of gene therapy to patients involving harvesting a patient's white blood cells, transducing or combining white blood cells with gene encoding T-cell receptor and re-administration of white blood cells to patient; Medical and therapeutic services, namely immunotherapy services comprising harvesting a patient's white blood cells, transducing the white blood cells with the gene encoding the engineered T-cell receptor and re-administration of the transduced white blood cells back into the patient
adaptimmune

General Information


Serial Number79171893
Word MarkADAPTIMMUNE
Filing DateMonday, June 29, 2015
Status706 - SECTION 71 ACCEPTED
Status DateThursday, June 9, 2022
Registration Number4934679
Registration DateTuesday, April 12, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 26, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer and autoimmune diseases
Goods and ServicesMedical treatment services, namely, administration of gene therapy to patients involving harvesting a patient's white blood cells, transducing or combining white blood cells with gene encoding T-cell receptor and re-administration of white blood cells to patient; Medical and therapeutic services, namely immunotherapy services comprising harvesting a patient's white blood cells, transducing the white blood cells with the gene encoding the engineered T-cell receptor and re-administration of the transduced white blood cells back into the patient

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 8, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 8, 2015
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAdaptimmune Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressOxfordshire OX14 4RX
GB

Party NameAdaptimmune Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameAdaptimmune Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, June 9, 2022NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Thursday, June 9, 2022REGISTERED-SEC.71 ACCEPTED
Monday, June 6, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 17, 2021TEAS SECTION 71 RECEIVED
Monday, April 12, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, July 26, 2019NEW REPRESENTATIVE AT IB RECEIVED
Thursday, November 2, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, July 29, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, July 13, 2016FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, July 13, 2016FINAL DISPOSITION PROCESSED
Tuesday, July 12, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 12, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, January 26, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 26, 2016PUBLISHED FOR OPPOSITION
Wednesday, January 6, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 17, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 30, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 30, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 30, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 30, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 30, 2015REFUSAL PROCESSED BY IB
Tuesday, October 13, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, October 13, 2015REFUSAL PROCESSED BY MPU
Saturday, October 10, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, October 9, 2015NON-FINAL ACTION WRITTEN
Wednesday, October 7, 2015ASSIGNED TO EXAMINER
Saturday, September 12, 2015APPLICATION FILING RECEIPT MAILED
Tuesday, September 8, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 3, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB